NASDAQ · HYPDHealthcarePharmaceuticals

Hyperion DeFi financials

$3.99+1.92%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$813.5K
Gross profit$510.2K
Gross margin62.7%
Operating income-$46.2M
Net income-$47.0M
Net margin−5777.7%
Diluted EPS$-9.40
EBITDA-$19.0M
Operating cash flow-$14.8M
Free cash flow-$14.8M
Diluted shares5.0M

Balance sheet

Period endDec 31
Cash & equivalents$6.3M
Short-term investments$0.00
Total debt$7.8M
Total assets$51.8M
Total liabilities$10.7M
Shareholders' equity$41.1M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology